Exactech, Inc.

276 articles about Exactech, Inc.

• Exactech AI Ecosystem of Smart Solutions to be Showcased at the 2024 AAOS Annual Meeting - Booth 951

  2/12/2024

  Exactech will showcase a full lineup of innovative implants and enabling technologies this week at the American Academy of Orthopaedic Surgeons (AAOS) 2024 Annual Meeting, Booth 951, in San Francisco, Ca.

• Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

  12/5/2023

  Exactech announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA).

• Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

  11/20/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced its Active Intelligence® platform surpassed more than 100,000 total joint replacement surgeries across the globe.

• Exactech Announces First Surgeries Using Activit-E™ for Knee Replacement

  10/31/2023

  Exactech announced the successful first surgery using its new, advanced Activit-E™ polyethylene for the Truliant® knee replacement system.

• Exactech Presents New Shoulder Research Studies at Global Conference

  9/14/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, presented 21 new scientific and clinical studies on the company’s Equinoxe® shoulder at the 2023 International Congress on Shoulder and Elbow Surgery (ICSES) annual meeting Sept. 5-8 in Rome.

• Exactech Debuts New Primary Knee System: TriVerse™

  9/5/2023

  Exactech announced first cases with the TriVerse™ primary knee system, an evidence-based, streamlined solution that is designed to address the ever-increasing demands of ’s active knee replacement patients.

• Exactech Announces FDA 510(k) Clearance for Advanced Activit-E™ Knee Replacement Polyethylene

  8/21/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced 510(k) clearance from the U.S. Food and Drug Administration for its new, advanced Activit-E™ polyethylene for the Truliant® knee replacement system.

• Exactech Announces First Surgery in the Middle East and Global Release of Next Generation GPS Shoulder

  5/30/2023

  Exactech announced their first surgery in the United Arab Emirates earlier this month, which leveraged the company’s Active Intelligence® suite, using ExactechGPS® and the Equinoxe® Planning App.

• Exactech Announces First Total Ankle Surgeries in South America

  5/22/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced first surgeries in Latin America with the Vantage® Total Ankle Fixed Bearing System.

• Exactech Accelerates International Expansion of Its Newton™ Balanced Knee Technology

  5/16/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced plans to accelerate the expansion of the Newton™ Knee to the Asia-Pacific region.

• Exactech Humeral Reconstruction Prosthesis Two-Year Patient Outcomes Demonstrate Significant Improvements in Pain and Range of Motion, No Cases of Humeral Loosening

  5/1/2023

  Exactech announced that a new study1 that shows positive two-year outcomes for the Equinoxe® Humeral Reconstruction Prosthesis, a solution for extensive proximal humerus bone loss, has just been published in the Journal of Shoulder and Elbow Surgery.

• New Exactech Knee Research Demonstrates Ability to Achieve Balanced Results with Short Learning Curve Using Newton™ Technology

  4/26/2023

  Exactech announced a new study published in the Journal of Arthroplasty that showcases the ability of the Newton™ knee balancing technology to execute dynamic joint balance with a short learning curve.

• Exactech Presents Latest Research Discoveries at 2023 Orthopaedic Research Society Meeting

  2/21/2023

  Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced that 12 studies containing newly discovered scientific and clinical data on the company’s knee and shoulder replacement solutions were presented at the 2023 Orthopaedic Research Society (ORS) annual meeting, on Feb. 10-14 in Dallas, Texas.

• New Published Study: Innovative Products Create Value for Shoulder Arthroplasty Patients

  1/31/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announces publication of a landmark new clinical study which demonstrates the value creation associated with the rapid adoption of novel shoulder arthroplasty technologies.

• Exactech and JointMedica Announce First Hip Resurfacing Procedure with Polymotion® Hip Implant

  1/10/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, is pleased to announce the first hip resurfacing surgery was successfully completed using the novel JointMedica Polymotion® hip implant that is based on a metal-on-polyethylene articulation.

• New Studies Demonstrate Benefits of Using Preoperative Planning and Navigation in Shoulder Surgery

  1/9/2023

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announces publication of two new studies that show positive clinical outcomes using the Equinoxe® shoulder preoperative Planning App and ExactechGPS® shoulder intraoperative navigation system.

• US Patent Issued for Exactech's Predict+™, First Machine Learning-Based Software that Informs Surgeons with Patient-Specific Outcome Predictions after Shoulder Replacement Surgery

  11/9/2022

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today that it has been granted patent #11,490,966 by the United States Patent and Trademark Office.

• Exactech Announces FDA 510(k) Clearance of the TriVerse™ Primary Knee Replacement System

  11/4/2022

  Exactech announced today 510(k) clearance from the U.S. Food and Drug Administration to market the TriVerse™ primary knee system.

• Exactech to Showcase New Innovations at AAHKS 2022 Annual Meeting, Booth #1101

  11/3/2022

  Exactech announced today its lineup of innovations for hip and knee arthroplasty to be showcased at this year's American Association of Hip and Knee Surgeons (AAHKS) meeting.

• Exactech Names New Chief Financial Officer

  10/4/2022

  Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, has appointed Tony Collins as its new Chief Financial Officer.